InspireMD, Inc.
NasdaqCM:NSPR
Sector
Industries
Location
Market Cap
USD 104.30 M
Share Price
USD 2.50
Avg Daily Volume
176,245
Change (1 day)
0.00%
Change (1 year)
-15.54%
Change (YTD)
-4.94%
InspireMD, Inc. Income Statement 2015 - 2025
This table shows the Income Statement for InspireMD, Inc. going from 2015 until 2025. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
Roche Holding AG
USD 331.61
RO.SW
+7.43
2.29%
Abbott Laboratories
USD 131.75
ABT
+2.47
1.91%
Thermo Fisher Scientific Inc.
USD 489.01
TMO
+3.97
0.82%
Boston Scientific Corporation
USD 103.17
BSX
-0.98
-0.94%
Stryker Corporation
USD 381.91
SYK
+3.39
0.90%
Medtronic plc
USD 93.02
MDT
+1.04
1.13%
Zoetis Inc.
USD 154.11
ZTS
+1.05
0.69%
Siemens Healthineers AG
USD 55.10
SHL.DE
+0.60
1.10%
Becton, Dickinson and Company
USD 195.94
BDX
+0.94
0.48%
IDEXX Laboratories, Inc.
USD 650.84
IDXX
-3.11
-0.48%
Edwards Lifesciences Corporation
USD 78.26
EW
+0.08
0.10%
Agilent Technologies, Inc.
USD 119.20
A
+0.33
0.28%
DexCom, Inc.
USD 80.95
DXCM
+0.99
1.24%
Fresenius SE & Co. KGaA
USD 53.85
FRE.DE
+0.19
0.35%
Terumo Corporation
USD 18.69
4543.T
+0.09
0.48%